Skip to main content
SpringerLink
Log in

Costs and burden of ankylosing spondylitis in China

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2012 values

Reference

  • Tu L, et al. Costs and work limitation of patients with ankylosing spondylitis in China. Clinical and Experimental Rheumatology : 19 Sep 2014. Available from: URL: http://doi.org/7790 [pii]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs and burden of ankylosing spondylitis in China. PharmacoEcon Outcomes News 713, 13 (2014). https://doi.org/10.1007/s40274-014-1598-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1598-0

Search

Navigation